The market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), ValGenesis, Inc., has announced the opening of its new subsidiary in the Netherlands. The subsidiary will assist ValGenesis’s expansion in European market along with ground sales and customer support for current clients and prospective clients in Europe.
According to Mr. Robert van der Laan, Managing Director of ValGenesis EMEA:
“The European clients and prospects have been keen adopters of new technologies, and we are encouraged with the traction we have seen in Europe, and our strengthened local presence in this market will enable our customers to embrace a new digital approach to all types of validation processes.”
VLMS is an effective tool for managing all types of validation activities such as equipment, instruments, computer systems, cleaning, analytical methods, and process validation while covering the entire validation lifecycle process thereby delivering technology solutions that are validated, fully configurable and rapidly deployable through a validated private secured cloud environment.
Dr. Siva Samy, CEO & Chief Product Strategist of ValGenesis further said:
“ValGenesis’ decision to expand operations in Europe was based on increasing global demand for and adoption of its Electronic Validation Lifecycle management system. ValGenesis has thousands of users using the ValGenesis VLMS as a system of record across Europe from 2010. The investment is yet another milestone for the rapidly growing company, which increased in size by approximately 50 percent in both employee count and revenues in 2017, and is expected to grow even faster in 2018.”
Headquartered in the USA, Valgenesis, Inc. designs and develops healthcare software. Valgenesis offers various services such as equipment validation, risk management, content management, test case execution, business process modeling, integration, and support services.